Clinical Trial Result Information

Title of Study:
This is an open-label, prospective, randomized, controlled multi-center study assessing fixed dose vs concentration controlled CellCept® regimens for patients following a single organ renal transplantation in combination with full dose and reduced dose calcineurin inhibitors

Fast Facts:

Protocol number:	ML17225
Sponsor:	Roche Laboratories Inc.
Company division:	Pharmaceutical
Product name:	CellCept
Generic name:	mycophenolate mofetil
Phase of development:	IV
Therapeutic area, approved indication:	Kidney Transplantation
Date of report:	To be Published

Clinical study summary:
This trial does not yet have clinical trial results posted on this website. All trial results will be posted within one year of approval or one year after trial completion, unless the release of information is restricted due to journal publication timing or pending regulatory filing. For further information on the timing of posting clinical trial results please consult the Roche policy for posting information on this website.

Click here for the protocol registry listing of this trial.